Q2 2023 Holdings
Filed 2023-08-14 | 51 holdings | $735.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $56.9M | 625,000 | 7.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $53.8M | 1,650,000 | 7.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.7M | 2,250,000 | 5.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $41.1M | 1,750,000 | 5.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $34.4M | 300,000 | 4.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $33.8M | 3,743,875 | 4.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $30.0M | 500,000 | 4.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $28.5M | 100,000 | 3.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $28.3M | 300,000 | 3.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $26.8M | 1,125,000 | 3.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $24.3M | 520,000 | 3.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $22.9M | 5,250,000 | 3.1% |
| Icosavax Inc | COM | 45114M109 | $21.5M | 2,165,741 | 2.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $20.0M | 1,780,000 | 2.7% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $17.6M | 2,797,501 | 2.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.6M | 400,000 | 2.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $15.8M | 500,000 | 2.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $15.2M | 750,000 | 2.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $13.3M | 520,000 | 1.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.3M | 3,500,000 | 1.7% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $11.2M | 650,000 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.6M | 275,000 | 1.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $10.2M | 250,000 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.5M | 800,000 | 1.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $9.2M | 2,800,000 | 1.3% |
| Morphosys AG | SPONSORED ADS | 617760202 | $9.0M | 1,200,000 | 1.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.7M | 100,000 | 1.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $8.2M | 250,000 | 1.1% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $7.8M | 650,000 | 1.1% |
| Karuna Therapeutics Inc | COM | 48576A100 | $7.6M | 35,000 | 1.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $7.5M | 1,000,000 | 1.0% |
| Geron Corp(GERN) | COM | 374163103 | $7.1M | 2,200,000 | 1.0% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $6.9M | 1,178,787 | 0.9% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $6.9M | 1,800,000 | 0.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $6.3M | 307,076 | 0.9% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.8M | 500,000 | 0.8% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $5.7M | 525,000 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.4M | 525,000 | 0.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.3M | 500,000 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.2M | 300,000 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.0M | 250,000 | 0.7% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $4.9M | 200,000 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.5M | 544,960 | 0.6% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $3.5M | 600,000 | 0.5% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $2.3M | 1,200,000 | 0.3% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.8M | 188,390 | 0.2% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.4M | 3,142,880 | 0.2% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $1.1M | 421,184 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $638.4K | 280,000 | 0.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $542.8K | 31,872 | 0.1% |